{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:05:26Z","timestamp":1789405526496,"version":"build-2803163510"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12035-021-02344-7","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T03:02:52Z","timestamp":1615172572000},"page":"3347-3361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19"],"prefix":"10.1007","volume":"58","author":[{"given":"Ranjana","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhriti","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8312-453X","authenticated-orcid":false,"given":"Anurag","family":"Kuhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"2344_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14776\/piv.2020.27.e9","volume":"27","author":"SE Park","year":"2020","unstructured":"Park SE (2020) Epidemiology, virology, and clinical features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; coronavirus disease-19). Pediatr Infect Vaccine 27:1\u201310. https:\/\/doi.org\/10.14776\/piv.2020.27.e9","journal-title":"Pediatr Infect Vaccine"},{"key":"2344_CR2","doi-asserted-by":"publisher","first-page":"104212","DOI":"10.1016\/j.meegid.2020.104212","volume":"79","author":"D Paraskevis","year":"2020","unstructured":"Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S (2020) Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 79:104212. https:\/\/doi.org\/10.1016\/j.meegid.2020.104212","journal-title":"Infect Genet Evol"},{"key":"2344_CR3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya AE, Baker SC, Baric RS et al (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536\u2013544. https:\/\/doi.org\/10.1038\/s41564-020-0695-z","journal-title":"Nat Microbiol"},{"key":"2344_CR4","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19 - 11 March 2020"},{"key":"2344_CR5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00415-020-09896-z","volume":"267","author":"M Leonardi","year":"2020","unstructured":"Leonardi M, Padovani A, McArthur JC (2020) Neurological manifestations associated with COVID-19: a review and a call for action. J. Neurol. 267:1573\u20131576","journal-title":"J. Neurol."},{"key":"2344_CR6","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s00415-020-09939-5","volume":"267","author":"P Gklinos","year":"2020","unstructured":"Gklinos P (2020) Neurological manifestations of COVID-19: a review of what we know so far. J. Neurol. 267:2485\u20132489","journal-title":"J. Neurol."},{"key":"2344_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","volume":"87","author":"Y Wu","year":"2020","unstructured":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Brain , behavior , and immunity nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 87:18\u201322. https:\/\/doi.org\/10.1016\/j.bbi.2020.03.031","journal-title":"Brain Behav Immun"},{"key":"2344_CR8","doi-asserted-by":"publisher","unstructured":"Mao L, Wang M, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D et al (2020) Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. SSRN Electron J. https:\/\/doi.org\/10.2139\/ssrn.3544840","DOI":"10.2139\/ssrn.3544840"},{"key":"2344_CR9","doi-asserted-by":"publisher","first-page":"116969","DOI":"10.1016\/j.jns.2020.116969","volume":"415","author":"P Pinna","year":"2020","unstructured":"Pinna P, Grewal P, Hall JP, Tavarez T, Dafer RM, Garg R, Osteraas ND, Pellack DR et al (2020) Neurological manifestations and COVID-19: experiences from a tertiary care center at the frontline. J Neurol Sci 415:116969. https:\/\/doi.org\/10.1016\/j.jns.2020.116969","journal-title":"J Neurol Sci"},{"key":"2344_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","volume":"7","author":"A Varatharaj","year":"2020","unstructured":"Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A et al (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry 7:875\u2013882. https:\/\/doi.org\/10.1016\/S2215-0366(20)30287-X","journal-title":"The Lancet Psychiatry"},{"key":"2344_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s13365-020-00895-4","volume":"26","author":"F Khatoon","year":"2020","unstructured":"Khatoon F, Prasad K, Kumar V (2020) Neurological manifestations of COVID-19: available evidences and a new paradigm. J Neurovirol 26:619\u2013630. https:\/\/doi.org\/10.1007\/s13365-020-00895-4","journal-title":"J Neurovirol"},{"key":"2344_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"2344_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K et al (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 71:762\u2013768. https:\/\/doi.org\/10.1093\/cid\/ciaa248","journal-title":"Clin Infect Dis"},{"key":"2344_CR14","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130:2620\u20132629. https:\/\/doi.org\/10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"2344_CR15","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e343","volume":"35","author":"KM Sohn","year":"2020","unstructured":"Sohn KM, Lee S-G, Kim HJ, Cheon S, Jeong H, Lee J, Kim IS, Silwal P et al (2020) COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis. J Korean Med Sci 35:e343. https:\/\/doi.org\/10.3346\/jkms.2020.35.e343","journal-title":"J Korean Med Sci"},{"key":"2344_CR16","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct. Target. Ther. 2:17023","journal-title":"Signal Transduct. Target. Ther."},{"key":"2344_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1134\/S0006297920070111","volume":"85","author":"RA Zinovkin","year":"2020","unstructured":"Zinovkin RA, Grebenchikov OA (2020) Transcription factor Nrf2 as a potential therapeutic target for prevention of cytokine storm in COVID-19 patients. Biochem 85:833\u2013837. https:\/\/doi.org\/10.1134\/S0006297920070111","journal-title":"Biochem"},{"key":"2344_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18764-3","volume":"11","author":"D Olagnier","year":"2020","unstructured":"Olagnier D, Farahani E, Thyrsted J, Blay-Cadanet J, Herengt A, Idorn M, Hait A, Hernaez B et al (2020) SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun 11:1\u201312. https:\/\/doi.org\/10.1038\/s41467-020-18764-3","journal-title":"Nat Commun"},{"key":"2344_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox9060518","volume":"9","author":"JM McCord","year":"2020","unstructured":"McCord JM, Hybertson BM, Cota-Gomez A et al (2020) Nrf2 activator pb125\u00ae as a potential therapeutic agent against covid-19. Antioxidants 9:1\u201315. https:\/\/doi.org\/10.3390\/antiox9060518","journal-title":"Antioxidants"},{"key":"2344_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/jnr.24357","volume":"97","author":"Y Tian","year":"2019","unstructured":"Tian Y, Wang W, Xu L, Li H, Wei Y, Wu Q, Jia J (2019) Activation of Nrf2\/ARE pathway alleviates the cognitive deficits in PS1V97L-Tg mouse model of Alzheimer\u2019s disease through modulation of oxidative stress. J Neurosci Res 97:492\u2013505. https:\/\/doi.org\/10.1002\/jnr.24357","journal-title":"J Neurosci Res"},{"key":"2344_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","volume":"14","author":"I Astuti","year":"2020","unstructured":"Astuti I, Ysrafil (2020) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr Clin Res Rev 14:407\u2013412. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"2344_CR22","doi-asserted-by":"publisher","unstructured":"Mousavizadeh L, Ghasemi S (2020) Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. https:\/\/doi.org\/10.1016\/j.jmii.2020.03.022","DOI":"10.1016\/j.jmii.2020.03.022"},{"key":"2344_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12015-020-09976-7","volume":"16","author":"H Ulrich","year":"2020","unstructured":"Ulrich H, Pillat MM (2020) CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Reports 16:434\u2013440. https:\/\/doi.org\/10.1007\/s12015-020-09976-7","journal-title":"Stem Cell Rev Reports"},{"key":"2344_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, du P, Wei D, Zhang Y et al (2020) CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 5:1\u201310. https:\/\/doi.org\/10.1038\/s41392-020-00426-x","journal-title":"Signal Transduct Target Ther"},{"key":"2344_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1101\/2020.06.05.134114","volume":"865","author":"JL Daly","year":"2020","unstructured":"Daly JL, Simonetti B, Ant\u00f3n-Pl\u00e1garo C et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. bioRxiv 865:861\u2013865. https:\/\/doi.org\/10.1101\/2020.06.05.134114","journal-title":"bioRxiv"},{"key":"2344_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L, Ojha R, Pedro LD et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (80-) 370:856\u2013860. https:\/\/doi.org\/10.1126\/science.abd2985","journal-title":"Science (80-)"},{"key":"2344_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/j.pain.0000000000002097","volume":"162","author":"A Moutal","year":"2021","unstructured":"Moutal A, Martin LF, Boinon L, Gomez K, Ran D, Zhou Y, Stratton HJ, Cai S et al (2021) SARS-CoV-2 spike protein co-opts VEGF-A\/neuropilin-1 receptor signaling to induce analgesia. Pain 162:243\u2013252. https:\/\/doi.org\/10.1097\/j.pain.0000000000002097","journal-title":"Pain"},{"key":"2344_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA - J Am Med Assoc 323:1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"JAMA - J Am Med Assoc"},{"key":"2344_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"2344_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03121-z","volume":"24","author":"G Nepal","year":"2020","unstructured":"Nepal G, Rehrig JH, Shrestha GS, Shing YK, Yadav JK, Ojha R, Pokhrel G, Tu ZL et al (2020) Neurological manifestations of COVID-19: a systematic review. Crit Care 24:1\u201311. https:\/\/doi.org\/10.1186\/s13054-020-03121-z","journal-title":"Crit Care"},{"key":"2344_CR31","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/nejmc2008597","volume":"382","author":"J Helms","year":"2020","unstructured":"Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C et al (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382:2268\u20132270. https:\/\/doi.org\/10.1056\/nejmc2008597","journal-title":"N Engl J Med"},{"key":"2344_CR32","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1007\/s00415-020-09986-y","volume":"267","author":"H Chaumont","year":"2020","unstructured":"Chaumont H, San-Galli A, Martino F, Couratier C, Joguet G, Carles M, Roze E, Lannuzel A (2020) Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection. J. Neurol. 267:3121\u20133127","journal-title":"J. Neurol."},{"key":"2344_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s41999-020-00353-8","volume":"11","author":"BC Mcloughlin","year":"2020","unstructured":"Mcloughlin BC, Miles A, Webb TE, Knopp P, Eyres C, Fabbri A, Humphries F, Davis D (2020) Functional and cognitive outcomes after COVID-19 delirium. Eur Geriatr Med 11:857\u2013862. https:\/\/doi.org\/10.1007\/s41999-020-00353-8","journal-title":"Eur Geriatr Med"},{"key":"2344_CR34","doi-asserted-by":"publisher","unstructured":"Gulko E, Oleksk ML, Gomes W et al (2020) mri brain findings in 126 patients with covid-19: initial observations from a descriptive literature review. Am J Neuroradiol:1\u20135. https:\/\/doi.org\/10.3174\/ajnr.a6805","DOI":"10.3174\/ajnr.a6805"},{"key":"2344_CR35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/cid\/ciaa330","volume":"71","author":"A Giacomelli","year":"2020","unstructured":"Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, Rusconi S, Gervasoni C et al (2020) Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin. Infect. Dis. 71:889\u2013890","journal-title":"Clin. Infect. Dis."},{"key":"2344_CR36","unstructured":"(OMS) WHO (2020) COVID-19 Weekly Epidemiological Update. November 1;4"},{"key":"2344_CR37","unstructured":"(OMS) WHO (2020) COVID-19 Weekly Epidemiological Update. December 1;4"},{"key":"2344_CR38","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard"},{"key":"2344_CR39","doi-asserted-by":"publisher","first-page":"40129","DOI":"10.1136\/bmjopen-2020-040129","volume":"10","author":"BB Abate","year":"2020","unstructured":"Abate BB, Kassie AM, Kassaw MW et al (2020) Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis. BMJ Open 10:40129","journal-title":"BMJ Open"},{"key":"2344_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"J-M Jin","year":"2020","unstructured":"Jin J-M, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK (2020) Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Heal 8:152. https:\/\/doi.org\/10.3389\/fpubh.2020.00152","journal-title":"Front Public Heal"},{"key":"2344_CR41","doi-asserted-by":"publisher","first-page":"200247","DOI":"10.5888\/pcd17.200247","volume":"17","author":"DM Griffith","year":"2020","unstructured":"Griffith DM, Sharma G, Holliday CS, Enyia OK, Valliere M, Semlow AR, Stewart EC, Blumenthal RS (2020) Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Prev Chronic Dis 17:200247. https:\/\/doi.org\/10.5888\/pcd17.200247","journal-title":"Prev Chronic Dis"},{"issue":"6","key":"2344_CR42","first-page":"1011","volume":"39","author":"H Ge","year":"2020","unstructured":"Ge H, Wang X, Yuan X et al (2020) The epidemiology and clinical information about. COVID-19 39(6):1011\u20131019","journal-title":"COVID-19"},{"key":"2344_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","volume":"87","author":"T Singhal","year":"2020","unstructured":"Singhal T (2020) Review on COVID19 disease so far. Indian J Pediatr 87:281\u2013286","journal-title":"Indian J Pediatr"},{"key":"2344_CR44","doi-asserted-by":"publisher","unstructured":"Yan R, Zhang Y, Li Y et al (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (80- ) 367:1444\u20131448. https:\/\/doi.org\/10.1126\/science.abb2762","DOI":"10.1126\/science.abb2762"},{"key":"2344_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18319-6","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Petitjean SJL, Koehler M, Zhang Q, Dumitru AC, Chen W, Derclaye S, Vincent SP et al (2020) Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun 11:1\u201321. https:\/\/doi.org\/10.1038\/s41467-020-18319-6","journal-title":"Nat Commun"},{"key":"2344_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631\u2013637. https:\/\/doi.org\/10.1002\/path.1570","journal-title":"A first step in understanding SARS pathogenesis. J Pathol"},{"key":"2344_CR47","doi-asserted-by":"publisher","unstructured":"Parasher A (2020) COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J postgradmedj-2020-138577. https:\/\/doi.org\/10.1136\/postgradmedj-2020-138577","DOI":"10.1136\/postgradmedj-2020-138577"},{"key":"2344_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1183\/13993003.00607-2020","volume":"55","author":"RJ Mason","year":"2020","unstructured":"Mason RJ (2020) Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J 55:9\u201311. https:\/\/doi.org\/10.1183\/13993003.00607-2020","journal-title":"Eur Respir J"},{"key":"2344_CR49","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1126\/science.1683005","volume":"254","author":"JC Smith","year":"1991","unstructured":"Smith JC, Ellenberger HH, Ballanyi K et al (1991) Pre-B\u00f6tzinger complex: a brainstem region that may generate respiratory rhythm in mammals. Science (80- ) 254:726\u2013729. https:\/\/doi.org\/10.1126\/science.1683005","journal-title":"Science (80- )"},{"issue":"8","key":"2344_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003034","volume":"3","author":"T Burgold","year":"2008","unstructured":"Burgold T, Spreafico F, De Santa F et al (2008) The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PLoS One 3(8):e3034. https:\/\/doi.org\/10.1371\/journal.pone.0003034","journal-title":"PLoS One"},{"key":"2344_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/svn-2020-000431","volume":"5","author":"Y Li","year":"2020","unstructured":"Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, Wang D, Mao L et al (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5:279\u2013284. https:\/\/doi.org\/10.1136\/svn-2020-000431","journal-title":"Stroke Vasc Neurol"},{"key":"2344_CR52","doi-asserted-by":"publisher","first-page":"588872","DOI":"10.3389\/fnagi.2020.588872","volume":"12","author":"S Alonso-Lana","year":"2020","unstructured":"Alonso-Lana S, Marqui\u00e9 M, Ruiz A, Boada M (2020) Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front. Aging Neurosci. 12:588872","journal-title":"Front. Aging Neurosci."},{"key":"2344_CR53","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/head.13856","volume":"60","author":"H Bolay","year":"2020","unstructured":"Bolay H, G\u00fcl A, Baykan B (2020) COVID-19 is a real headache! Headache 60:1415\u20131421. https:\/\/doi.org\/10.1111\/head.13856","journal-title":"Headache"},{"key":"2344_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 191:9\u201314. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.024","journal-title":"Thromb Res"},{"key":"2344_CR55","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12975-020-00818-9","volume":"11","author":"DC Hess","year":"2020","unstructured":"Hess DC, Eldahshan W, Rutkowski E (2020) COVID-19-related stroke. Transl. Stroke Res. 11:322\u2013325","journal-title":"Transl. Stroke Res."},{"key":"2344_CR56","doi-asserted-by":"publisher","first-page":"100669","DOI":"10.1016\/j.nmni.2020.100669","volume":"35","author":"A Sharifi-Razavi","year":"2020","unstructured":"Sharifi-Razavi A, Karimi N, Rouhani N (2020) COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect 35:100669. https:\/\/doi.org\/10.1016\/j.nmni.2020.100669","journal-title":"New Microbes New Infect"},{"key":"2344_CR57","doi-asserted-by":"publisher","first-page":"117085","DOI":"10.1016\/j.jns.2020.117085","volume":"417","author":"M Sharifian-Dorche","year":"2020","unstructured":"Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, Antel JP, Mowla A (2020) Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J. Neurol. Sci. 417:117085","journal-title":"J. Neurol. Sci."},{"key":"2344_CR58","doi-asserted-by":"publisher","unstructured":"Zhao K, Huang J, Dai D et al (2020) Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv 2020.03.16.20035105. https:\/\/doi.org\/10.1101\/2020.03.16.20035105","DOI":"10.1101\/2020.03.16.20035105"},{"key":"2344_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"T Moriguchi","year":"2020","unstructured":"Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H et al (2020) A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55\u201358. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.062","journal-title":"Int J Infect Dis"},{"key":"2344_CR60","doi-asserted-by":"publisher","first-page":"560","DOI":"10.4103\/0028-3886.289000","volume":"68","author":"R Garg","year":"2020","unstructured":"Garg R (2020) Spectrum of neurological manifestations in Covid-19: a review. Neurol India 68:560\u2013572. https:\/\/doi.org\/10.4103\/0028-3886.289000","journal-title":"Neurol India"},{"key":"2344_CR61","doi-asserted-by":"publisher","first-page":"E223","DOI":"10.1148\/radiol.2020202040","volume":"297","author":"A Radmanesh","year":"2020","unstructured":"Radmanesh A, Derman A, Lui YW, Raz E, Loh JP, Hagiwara M, Borja MJ, Zan E et al (2020) COVID-19\u2013associated diffuse leukoencephalopathy and microhemorrhages. Radiology 297:E223\u2013E227. https:\/\/doi.org\/10.1148\/radiol.2020202040","journal-title":"Radiology"},{"key":"2344_CR62","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1212\/WNL.0000000000010250","volume":"95","author":"J Virhammar","year":"2020","unstructured":"Virhammar J, Kumlien E, F\u00e4llmar D, Frithiof R, Jackmann S, Sk\u00f6ld MK, Kadir M, Frick J et al (2020) Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology 95:445\u2013449. https:\/\/doi.org\/10.1212\/WNL.0000000000010250","journal-title":"Neurology"},{"key":"2344_CR63","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/jmv.26113","volume":"92","author":"S Elgamasy","year":"2020","unstructured":"Elgamasy S, Kamel MG, Ghozy S, Khalil A, Morra ME, Islam SMS (2020) First case of focal epilepsy associated with SARS-coronavirus-2. J Med Virol 92:2238\u20132242. https:\/\/doi.org\/10.1002\/jmv.26113","journal-title":"J Med Virol"},{"key":"2344_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12028-020-01006-1","volume":"28","author":"M Hepburn","year":"2020","unstructured":"Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A, Newey CR (2020) acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit Care 28:1\u20135. https:\/\/doi.org\/10.1007\/s12028-020-01006-1","journal-title":"Neurocrit Care"},{"key":"2344_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.seizure.2020.05.005","volume":"79","author":"AA Asadi-Pooya","year":"2020","unstructured":"Asadi-Pooya AA (2020) Seizures associated with coronavirus infections. Seizure 79:49\u201352","journal-title":"Seizure"},{"key":"2344_CR66","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpsychires.2020.06.022","volume":"129","author":"H Zhou","year":"2020","unstructured":"Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, Shi C, Hu S (2020) The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res 129:98\u2013102. https:\/\/doi.org\/10.1016\/j.jpsychires.2020.06.022","journal-title":"J Psychiatr Res"},{"key":"2344_CR67","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","volume":"77","author":"AS Zubair","year":"2020","unstructured":"Zubair AS, McAlpine LS, Gardin T et al (2020) Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review. JAMA Neurol. 77:1018\u20131027","journal-title":"JAMA Neurol."},{"key":"2344_CR68","doi-asserted-by":"publisher","unstructured":"Hawkes CH (2020) Smell, taste and Covid-19: testing is essential. QJM An Int J Med:1\u20139. https:\/\/doi.org\/10.1093\/qjmed\/hcaa326","DOI":"10.1093\/qjmed\/hcaa326"},{"key":"2344_CR69","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1212\/WNL.0000000000010280","volume":"95","author":"F Madia","year":"2020","unstructured":"Madia F, Merico B, Primiano G, Cutuli SL, de Pascale G, Servidei S (2020) Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit. Neurology 95:492\u2013494. https:\/\/doi.org\/10.1212\/WNL.0000000000010280","journal-title":"Neurology"},{"key":"2344_CR70","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.clinph.2020.06.003","volume":"131","author":"H Tankisi","year":"2020","unstructured":"Tankisi H, Tankisi A, Harbo T, Markvardsen LK, Andersen H, Pedersen TH (2020) Critical illness myopathy as a consequence of Covid-19 infection. Clin. Neurophysiol. 131:1931\u20131932","journal-title":"Clin. Neurophysiol."},{"key":"2344_CR71","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tins.2011.03.001","volume":"34","author":"H Gutierrez","year":"2011","unstructured":"Gutierrez H, Davies AM (2011) Regulation of neural process growth, elaboration and structural plasticity by NF-\u00ceoB. Trends Neurosci 34:316\u2013325. https:\/\/doi.org\/10.1016\/j.tins.2011.03.001","journal-title":"Trends Neurosci"},{"key":"2344_CR72","first-page":"73","volume":"8","author":"N Kopitar-Jeraia","year":"2015","unstructured":"Kopitar-Jeraia N (2015) Innate immune response in brain, nf-kappa b signaling and cystatins. Front. Mol. Neurosci. 8:73","journal-title":"Front. Mol. Neurosci."},{"key":"2344_CR73","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"RH Shih","year":"2015","unstructured":"Shih RH, Wang CY, Yang CM (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front. Mol. Neurosci. 8:77","journal-title":"Front. Mol. Neurosci."},{"key":"2344_CR74","doi-asserted-by":"publisher","first-page":"105921","DOI":"10.1016\/j.clineuro.2020.105921","volume":"194","author":"V Montalvan","year":"2020","unstructured":"Montalvan V, Lee J, Bueso T, de Toledo J, Rivas K (2020) Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin. Neurol. Neurosurg. 194:105921","journal-title":"Clin. Neurol. Neurosurg."},{"key":"2344_CR75","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.tem.2020.08.004","volume":"31","author":"P Guisado-Vasco","year":"2020","unstructured":"Guisado-Vasco P, Cano-Meg\u00edas M, Rodr\u00edguez-L\u00f3pez M, de-Luna-Boquera IM, Carnevali-Ruiz D, Immunosuppressants Against COVID-19 Working Team (2020) COVID-19 and metabolic syndrome: NF-\u03baB activation. Crossroads. Trends Endocrinol. Metab. 31:802\u2013803","journal-title":"Crossroads. Trends Endocrinol. Metab."},{"key":"2344_CR76","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1128\/jvi.02576-13","volume":"88","author":"ML DeDiego","year":"2014","unstructured":"DeDiego ML, Nieto-Torres JL, Regla-Nava JA et al (2014) Inhibition of NF- B-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol 88:913\u2013924. https:\/\/doi.org\/10.1128\/jvi.02576-13","journal-title":"J Virol"},{"key":"2344_CR77","doi-asserted-by":"crossref","unstructured":"Welcome MO, Precision T (2020) Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of Sars-Cov2 infection. Inflammopharmacology (pre-print)","DOI":"10.1007\/s10787-021-00806-x"},{"key":"2344_CR78","first-page":"134","volume":"74","author":"SM Hassan","year":"2020","unstructured":"Hassan SM, Jawad MJ, Ahjel SW et al (2020) The Nrf2 Activator (DMF) and Covid-19: is there a possible role? Med. Arch. (Sarajevo, Bosnia Herzegovina) 74:134\u2013138","journal-title":"Med. Arch. (Sarajevo, Bosnia Herzegovina)"},{"issue":"Pt B","key":"2344_CR79","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1759091419899782","volume":"88","author":"MS Brandes","year":"2020","unstructured":"Brandes MS, Gray NE (2020) NRF2 as a therapeutic target in neurodegenerative diseases. ASN Neuro 88(Pt B):253\u2013267. https:\/\/doi.org\/10.1177\/1759091419899782","journal-title":"ASN Neuro"},{"key":"2344_CR80","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","volume":"66","author":"CP Ramsey","year":"2007","unstructured":"Ramsey CP, Glass CA, Montgomery MB, Lindl KA, Ritson GP, Chia LA, Hamilton RL, Chu CT et al (2007) Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 66:75\u201385. https:\/\/doi.org\/10.1097\/nen.0b013e31802d6da9","journal-title":"J Neuropathol Exp Neurol"},{"key":"2344_CR81","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1371\/journal.pone.0006588","volume":"4","author":"Z Sun","year":"2009","unstructured":"Sun Z, Huang Z, Zhang DD (2009) Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS One 4:6588. https:\/\/doi.org\/10.1371\/journal.pone.0006588","journal-title":"PLoS One"},{"key":"2344_CR82","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/toxsci\/kfg083","volume":"73","author":"LM Zipper","year":"2003","unstructured":"Zipper LM (2003) Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol Sci 73:124\u2013134. https:\/\/doi.org\/10.1093\/toxsci\/kfg083","journal-title":"Toxicol Sci"},{"key":"2344_CR83","doi-asserted-by":"publisher","first-page":"110102","DOI":"10.1016\/j.mehy.2020.110102","volume":"143","author":"R Cecchini","year":"2020","unstructured":"Cecchini R, Cecchini AL (2020) SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med Hypotheses 143:110102. https:\/\/doi.org\/10.1016\/j.mehy.2020.110102","journal-title":"Med Hypotheses"},{"key":"2344_CR84","doi-asserted-by":"publisher","first-page":"217580","DOI":"10.1155\/2012\/217580","volume":"2012","author":"H Pan","year":"2012","unstructured":"Pan H, Wang H, Wang X, Zhu L, Mao L (2012) The absence of Nrf2 enhances NF-\u03baB-dependent inflammation following scratch injury in mouse primary cultured astrocytes. Mediators Inflamm 2012:217580\u2013217589. https:\/\/doi.org\/10.1155\/2012\/217580","journal-title":"Mediators Inflamm"},{"key":"2344_CR85","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1172\/JCI25790","volume":"116","author":"RK Thimmulappa","year":"2006","unstructured":"Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S (2006) Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116:984\u2013995. https:\/\/doi.org\/10.1172\/JCI25790","journal-title":"J Clin Invest"},{"key":"2344_CR86","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.redox.2013.07.005","volume":"1","author":"V Ganesh Yerra","year":"2013","unstructured":"Ganesh Yerra V, Negi G, Sharma SS, Kumar A (2013) Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-\u03baB pathways in diabetic neuropathy. Redox Biol. 1:394\u2013397","journal-title":"Redox Biol."},{"key":"2344_CR87","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM (2015) Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem Soc Trans 43:621\u2013626. https:\/\/doi.org\/10.1042\/BST20150014","journal-title":"Biochem Soc Trans"},{"key":"2344_CR88","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.4049\/jimmunol.172.6.3553","volume":"172","author":"MP Soares","year":"2004","unstructured":"Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, Bach FH (2004) Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172:3553\u20133563. https:\/\/doi.org\/10.4049\/jimmunol.172.6.3553","journal-title":"J Immunol"},{"key":"2344_CR89","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/J.BBAMCR.2008.01.002","volume":"1783","author":"G-H Liu","year":"2008","unstructured":"Liu G-H, Qu J, Shen X (2008) NF-\u03baB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta - Mol Cell Res 1783:713\u2013727. https:\/\/doi.org\/10.1016\/J.BBAMCR.2008.01.002","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"2344_CR90","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.cellsig.2010.06.004","volume":"22","author":"JE Kim","year":"2010","unstructured":"Kim JE, You DJ, Lee C, Ahn C, Seong JY, Hwang JI (2010) Suppression of NF-\u03baB signaling by KEAP1 regulation of IKK\u03b2 activity through autophagic degradation and inhibition of phosphorylation. Cell Signal 22:1645\u20131654. https:\/\/doi.org\/10.1016\/j.cellsig.2010.06.004","journal-title":"Cell Signal"},{"key":"2344_CR91","doi-asserted-by":"publisher","first-page":"e14627","DOI":"10.1111\/dth.14627","volume":"34","author":"A Druyan","year":"2021","unstructured":"Druyan A, Lidar M, Brodavka M, Levy I, Barzilai A, Pavlotsky F (2021) The risk for severe COVID- 19 in patients with autoimmune and\/or inflammatory diseases: first wave lessons. Dermatol Ther 34:e14627. https:\/\/doi.org\/10.1111\/dth.14627","journal-title":"Dermatol Ther"},{"key":"2344_CR92","doi-asserted-by":"publisher","first-page":"e00063","DOI":"10.1128\/MCB.00063-17","volume":"37","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Murakami S, Biswal SS, Sakaguchi S, Harigae H, Yamamoto M, Motohashi H (2017) Systemic activation of NRF2 alleviates lethal autoimmune inflammation in scurfy mice. Mol Cell Biol 37:e00063\u2013e00017. https:\/\/doi.org\/10.1128\/MCB.00063-17","journal-title":"Mol Cell Biol"},{"key":"2344_CR93","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","volume":"34","author":"SC Sun","year":"2013","unstructured":"Sun SC, Chang JH, Jin J (2013) Regulation of nuclear factor-\u03baB in autoimmunity. Trends Immunol. 34:282\u2013289","journal-title":"Trends Immunol."},{"key":"2344_CR94","doi-asserted-by":"publisher","first-page":"173643","DOI":"10.1016\/j.ejphar.2020.173643","volume":"890","author":"R Bhandari","year":"2020","unstructured":"Bhandari R, Khanna G, Kuhad A (2020) Pharmacological insight into potential therapeutic agents for the deadly Covid-19 pandemic. Eur J Pharmacol 890:173643. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173643","journal-title":"Eur J Pharmacol"},{"key":"2344_CR95","first-page":"3","volume":"1","author":"A Hariharan","year":"2020","unstructured":"Hariharan A, Hakeem AR, Radhakrishnan S et al (2020) The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients. Inflammopharmacology 1:3","journal-title":"Inflammopharmacology"},{"key":"2344_CR96","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/nejmoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY et al (2020) Remdesivir for the treatment of Covid-19 \u2014 final report. N Engl J Med 383:1813\u20131826. https:\/\/doi.org\/10.1056\/nejmoa2007764","journal-title":"N Engl J Med"},{"key":"2344_CR97","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0014-5793(00)01464-2","volume":"472","author":"SI Oka","year":"2000","unstructured":"Oka SI, Kamata H, Kamata K, Yagisawa H, Hirata H (2000) N-Acetylcysteine suppresses TNF-induced NF-\u03baB activation through inhibition of I\u03baB kinases. FEBS Lett 472:196\u2013202. https:\/\/doi.org\/10.1016\/S0014-5793(00)01464-2","journal-title":"FEBS Lett"},{"issue":"1","key":"2344_CR98","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","volume":"11","author":"D Olagnier","year":"2020","unstructured":"Olagnier D, Farahani E, Thyrsted J et al (2020) SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun 11(1):4938","journal-title":"Nat Commun"},{"key":"2344_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-5728(94)00140-J","volume":"56","author":"V Gallai","year":"1995","unstructured":"Gallai V, Sarchielli P, Trequattrini A, Franceschini M, Floridi A, Firenze C, Alberti A, di Benedetto D et al (1995) Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol 56:143\u2013153. https:\/\/doi.org\/10.1016\/0165-5728(94)00140-J","journal-title":"J Neuroimmunol"},{"key":"2344_CR100","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.14379","volume":"285","author":"AT Dinkova-Kostova","year":"2018","unstructured":"Dinkova-Kostova AT, Kostov RV, Kazantsev AG (2018) The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J. 285:3576\u20133590","journal-title":"FEBS J."},{"key":"2344_CR101","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3389\/fphar.2019.01597","volume":"10","author":"MM Serafini","year":"2020","unstructured":"Serafini MM, Catanzaro M, Fagiani F, Simoni E, Caporaso R, Dacrema M, Romanoni I, Govoni S et al (2020) Modulation of Keap1\/Nrf2\/ARE signaling pathway by curcuma- and garlic-derived hybrids. Front Pharmacol 10:1597. https:\/\/doi.org\/10.3389\/fphar.2019.01597","journal-title":"Front Pharmacol"},{"key":"2344_CR102","doi-asserted-by":"publisher","first-page":"110234","DOI":"10.1016\/j.biopha.2020.110234","volume":"127","author":"T Farkhondeh","year":"2020","unstructured":"Farkhondeh T, Folgado SL, Pourbagher-Shahri AM, Ashrafizadeh M, Samarghandian S (2020) The therapeutic effect of resveratrol: focusing on the Nrf2 signaling pathway. Biomed Pharmacother 127:110234. https:\/\/doi.org\/10.1016\/j.biopha.2020.110234","journal-title":"Biomed Pharmacother"},{"issue":"22","key":"2344_CR103","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.3390\/molecules24224097","volume":"24","author":"R Borella","year":"2019","unstructured":"Borella R, Forti L, Gibellini L, de Gaetano A, de Biasi S, Nasi M, Cossarizza A, Pinti M (2019) Synthesis and anticancer activity of CDDO and CDDO-me, two derivatives of natural triterpenoids. Molecules 24(22):4097","journal-title":"Molecules"},{"key":"2344_CR104","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1087057115617456","volume":"21","author":"FD Herrington","year":"2016","unstructured":"Herrington FD, Carmody RJ, Goodyear CS (2016) Modulation of NF-\u03baB signaling as a therapeutic target in autoimmunity. J. Biomol. Screen. 21:223\u2013242","journal-title":"J. Biomol. Screen."},{"key":"2344_CR105","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1080\/07391102.2018.1552623","volume":"37","author":"VS Silva","year":"2019","unstructured":"Silva VS, Vergara FM, Seito LN, Antunes D, Santos LHS, Henriques MG, Caffarena ER (2019) Thiophenacetamide as a potential modulator to NF-\u03baB: structure and dynamics study using in silico and molecular biology assays. J Biomol Struct Dyn 37:4395\u20134406. https:\/\/doi.org\/10.1080\/07391102.2018.1552623","journal-title":"J Biomol Struct Dyn"},{"key":"2344_CR106","doi-asserted-by":"publisher","unstructured":"Eudy BJ, Carter RE, Abed SA et al Activation of Nrf2 target genes by aged garlic extract in THP-1 macrophages: regulation by glutathione depletion. FASEB J 31:974.24-974.24. https:\/\/doi.org\/10.1096\/FASEBJ.31.1_SUPPLEMENT.974.24","DOI":"10.1096\/FASEBJ.31.1_SUPPLEMENT.974.24"},{"key":"2344_CR107","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/jn\/137.5.1208","volume":"137","author":"PA Ruiz","year":"2007","unstructured":"Ruiz PA, Braune A, H\u00f6lzlwimmer G et al (2007) Quercetin inhibits TNF-induced NF-\u03baB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr 137:1208\u20131215. https:\/\/doi.org\/10.1093\/jn\/137.5.1208","journal-title":"J Nutr"},{"key":"2344_CR108","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jep.2014.03.049","volume":"154","author":"SS Choudhury","year":"2014","unstructured":"Choudhury SS, Bashyam L, Manthapuram N, Bitla P, Kollipara P, Tetali SD (2014) Ocimum sanctum leaf extracts attenuate human monocytic (THP-1) cell activation. J Ethnopharmacol 154:148\u2013155. https:\/\/doi.org\/10.1016\/j.jep.2014.03.049","journal-title":"J Ethnopharmacol"},{"key":"2344_CR109","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2019.04.030","volume":"137","author":"JS Park","year":"2019","unstructured":"Park JS, Lee YS, Lee DH, Bae SH (2019) Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity. Free Radic Biol Med 137:143\u2013157. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.04.030","journal-title":"Free Radic Biol Med"},{"key":"2344_CR110","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.1007\/s13277-016-4798-3","volume":"37","author":"EA Assar","year":"2016","unstructured":"Assar EA, Vidalle MC, Chopra M, Hafizi S (2016) Lycopene acts through inhibition of I\u03baB kinase to suppress NF-\u03baB signaling in human prostate and breast cancer cells. Tumor Biol 37:9375\u20139385. https:\/\/doi.org\/10.1007\/s13277-016-4798-3","journal-title":"Tumor Biol"},{"key":"2344_CR111","doi-asserted-by":"publisher","first-page":"37","DOI":"10.15430\/jcp.2018.23.1.37","volume":"23","author":"SO Cho","year":"2018","unstructured":"Cho SO, Kim M-H, Kim H (2018) \u03b2-Carotene inhibits activation of NF-\u03baB, activator protein-1, and STAT3 and regulates abnormal expression of some adipokines in 3 T3-L1 Adipocytes. J Cancer Prev 23:37\u201343. https:\/\/doi.org\/10.15430\/jcp.2018.23.1.37","journal-title":"J Cancer Prev"},{"key":"2344_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-2-S1-S44","volume":"2","author":"S Pati","year":"2005","unstructured":"Pati S, Nguyen A, Foulke JS, Weichold F, Reitz M (2005) Ritonavir inhibits NF-AT activation through effects on the PI-3 kinase\/Akt pathway. Retrovirology 2:1\u20131. https:\/\/doi.org\/10.1186\/1742-4690-2-S1-S44","journal-title":"Retrovirology"},{"key":"2344_CR113","doi-asserted-by":"publisher","first-page":"111777","DOI":"10.1016\/j.ejmech.2019.111777","volume":"185","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Jang BK, Park JH, Choi JW, Park SJ, Byeon SR, Pae AN, Lee YS et al (2020) A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model. Eur J Med Chem 185:111777. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111777","journal-title":"Eur J Med Chem"},{"key":"2344_CR114","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jep.2010.03.040","volume":"130","author":"J Li","year":"2010","unstructured":"Li J, Ichikawa T, Jin Y, Hofseth LJ, Nagarkatti P, Nagarkatti M, Windust A, Cui T (2010) An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol 130:222\u2013230. https:\/\/doi.org\/10.1016\/j.jep.2010.03.040","journal-title":"J Ethnopharmacol"},{"key":"2344_CR115","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bbrc.2015.08.056","volume":"465","author":"JS Park","year":"2015","unstructured":"Park JS, Kang DH, Lee DH, Bae SH (2015) Fenofibrate activates Nrf2 through p62-dependent Keap1 degradation. Biochem Biophys Res Commun 465:542\u2013547. https:\/\/doi.org\/10.1016\/j.bbrc.2015.08.056","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02344-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02344-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02344-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T10:45:38Z","timestamp":1625481938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02344-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":115,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02344-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"8 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors have agreed upon the final version of the article before submission and their consent has been sought.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}